经尿道等离子双极电切术治疗高危前列腺增生症

The treatment of benign prostate hypertrophy in high risk patients by transurethral Plasmakinetic resection

目的:探讨高危前列腺增生症(BPH)患者经尿道等离子双极电切术(PKRP)治疗效果.方法:采用PKRP治疗高危BPH 患者72例,随访3～14个月.结果:前列腺重量25.1～125(59.2±31.9)g,手术时间30～190 min,平均(64 ±44)min. 最大尿流率由术前的(7.5±1.7)ml/s上升至术后3个月的(19.2±3.2)ml/s(P<0.01),国际前列腺症状评分术前为(22.6±1.5)分,术后3个月降至(7.2±1.3)分(P<0.01).结论:经尿道等离子双极电切术治疗高危BPH见效快,安全性好,并发症少.

Objective:In order to evaluate the validity of transurethral plasmakinetic resection of high risk benign prostatic hyperplasia 72 cases were analysed.Methods:72 cases of BPH we retreated by transurethral plasmakinetic resection of prostate (PKRP) and had been followed up at 3 and 14 months.Results:The weight of the prostate was 30-125 g, The mean weight of the prostate was ((59.7)(31.9))g. The operative time was 30-190min, The mean operative time was (6444) min. Peak urine flow in creased form ((7.5)(1.7))ml/s to ((19.2)(3.2))ml/s and I-PSS decreased from ((22.6)(1.5)) to ((7.2)(1.3)) at 3 months postoperatively (P<(0.01)).Conclusions:Transurethral plasmakinetic resection of prostate is safe and effective with less complications and good result. It was suggested that the procedure is safe and effective on therapy high risk patients with BPH.